This company listing is no longer active
8490 Stock Overview
Taiwan Leader Biotech Corp. researches, develops, and supplies herbal medicines, edible fungi, and other health supplements.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 5/6 |
Dividends | 0/6 |
Taiwan Leader Biotech Corp. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | NT$2.50 |
52 Week High | NT$16.80 |
52 Week Low | NT$2.05 |
Beta | 0.046 |
1 Month Change | -52.38% |
3 Month Change | -61.00% |
1 Year Change | -70.59% |
3 Year Change | -89.87% |
5 Year Change | -90.97% |
Change since IPO | -92.46% |
Recent News & Updates
Recent updates
Shareholder Returns
8490 | TW Personal Products | TW Market | |
---|---|---|---|
7D | 0% | 2.4% | 0.4% |
1Y | -70.6% | -8.1% | 27.1% |
Rentabilidad frente al sector: 8490 underperformed the TW Personal Products industry which returned 0.3% over the past year.
Rentabilidad vs. Mercado: 8490 underperformed the TW Market which returned -21% over the past year.
Price Volatility
8490 volatility | |
---|---|
8490 Average Weekly Movement | 14.5% |
Personal Products Industry Average Movement | 3.8% |
Market Average Movement | 4.3% |
10% most volatile stocks in TW Market | 8.2% |
10% least volatile stocks in TW Market | 1.9% |
Precio estable de las acciones: 8490's share price has been volatile over the past 3 months.
Volatilidad a lo largo del tiempo: 8490's weekly volatility (14%) has been stable over the past year, but is still higher than 75% of TW stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2006 | 33 | Chen Xiang | https://www.twleaderlife.com |
Taiwan Leader Biotech Corp. Fundamentals Summary
8490 fundamental statistics | |
---|---|
Market cap | NT$123.75m |
Earnings (TTM) | -NT$29.53m |
Revenue (TTM) | NT$39.91m |
3.1x
P/S Ratio-4.2x
P/E RatioIs 8490 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
8490 income statement (TTM) | |
---|---|
Revenue | NT$39.91m |
Cost of Revenue | NT$26.70m |
Gross Profit | NT$13.21m |
Other Expenses | NT$42.73m |
Earnings | -NT$29.53m |
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
n/a
Earnings per share (EPS) | -0.60 |
Gross Margin | 33.09% |
Net Profit Margin | -74.00% |
Debt/Equity Ratio | 27.2% |
How did 8490 perform over the long term?
See historical performance and comparison